Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas (Q40953737)

25 September 2017

title

Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas (English)

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

7 April 2023

0 references

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

7 April 2023

author name string

Einstein AB Jr

6

1 reference

25 September 2017

D. T. Harrison

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361208

7 April 2023

P. E. Neiman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361208

7 April 2023

K. Sullivan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361208

7 April 2023

M. Hafermann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361208

7 April 2023

R. H. Rudolph

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361208

7 April 2023

A. B. Einstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361208

7 April 2023

language of work or name

English

0 references

publication date

1 October 1978

1 reference

full work available at URL

25 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

7 April 2023

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

7 April 2023

1 reference

25 September 2017

volume

42

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

1697-1704

1 reference

Recurrence Rates Following Radiation Therapy of Nodular and Diffuse Malignant Lymphomas

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197810%2942%3A4%3C1697%3A%3AAID-CNCR2820420407%3E3.0.CO%3B2-G

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197810%2942%3A4%3C1697%3A%3AAID-CNCR2820420407%3E3.0.CO%3B2-G

Drugs 5 years later: procarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197810%2942%3A4%3C1697%3A%3AAID-CNCR2820420407%3E3.0.CO%3B2-G

Combination chemotherapy of lymphomas other than Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197810%2942%3A4%3C1697%3A%3AAID-CNCR2820420407%3E3.0.CO%3B2-G

Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

21 January 2018

1

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma

7 April 2023

3

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Total body irradiation as treatment for lymphosarcoma

7 April 2023

4

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Advanced diffuse histiocytic lymphoma, a potentially curable disease

7 April 2023

5

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Incidence, cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow

7 April 2023

6

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Primary management of advanced lymphosarcoma with radiotherapy

7 April 2023

9

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Remission induction and remission duration with primary radiotherapy in advanced lymphosarcoma

7 April 2023

10

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

7 April 2023

11

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Involvement of the central nervous system in non-hodgkin's lymphoma

7 April 2023

12

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

7 April 2023

13

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases

7 April 2023

15

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

The value of staging laparotomy in non-Hodgkin's lymphomas.(With emphasis on the histiocytic type)

7 April 2023

23

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy

7 April 2023

24

1 reference

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1697::AID-CNCR2820420407%3E3.0.CO;2-G

7 April 2023

Identifiers

10.1002/1097-0142(197810)42:4<1697::AID-CNCR2820420407>3.0.CO;2-G

1 reference

25 September 2017

1 reference